This Solicitation opportunity from Government of Canada was posted on March 12, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

RFP - Secondary Pandemic Influenza Vaccine (PIV) Readiness and Supply

Closed

WS4698221354International

Submission Closed06/11/2025, 02:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325414

New

International

Лікарські засоби (МНН: Rabies, inactivated, whole virus) (ІНДІРАБ ВАКЦИНА АНТИРАБІЧНА)

Solicitation # UA-2026-11-06-014068-a

This solicitation, issued by the Rivne Regional Children's Hospital under the Government of Ukraine, is for the procurement of inactivated whole virus rabies vaccines known as Indirab. The procurement process is identified by solicitation number UA-2026-11-06-014068-a, with a response deadline set for November 10, 2026. The performance of the contract will take place in Rivne, Rivne Oblast, Ukraine. Participants in this procurement are required to provide detailed information regarding their ultimate beneficial owners, particularly for non-resident entities. This mandatory disclosure must include the full name, citizenship, and the nature and extent of the beneficial ownership or influence. Additionally, for resident founders, the full name, location, and identification code of the legal entity must be submitted in a free-form format upon signing the contract.

Комунальне підприємство "Рівненська обласна дитяча лікарня" Рівненської обласної ради

POSTED

DEADLINE

Реагенти для лабораторії імуногенетичних технологій та біоінженерії – ДК 021:2015 – 33690000-3 - Лікарські засоби різні (КЛІТИННА ЛІНІЯ Nalm-6-Zellen – Код ДК 021:2015 – 33696500-0 - Лабораторні реактиви (НК 024:2023/НК 031:2024 – 30670 - Лінія клітинної

Solicitation # UA-2026-11-06-013516-a

The National Children's Specialized Hospital Okhmatdyt of the Ministry of Health of Ukraine is soliciting bids for the procurement of laboratory reagents, specifically the Nalm-6 cell line, for the Laboratory of Immunogenetic Technologies and Bioengineering. This solicitation, identified by number UA-2026-11-06-013516-a, is categorized under various medical and laboratory reagent codes. The performance of the contract and delivery of goods will take place in Kyiv, Ukraine. Interested parties must submit their responses by the deadline of November 22, 2026. A critical compliance requirement for this contract is that the goods provided cannot originate from the Russian Federation, the Republic of Belarus, or the Islamic Republic of Iran. Primary contact for this procurement is Maryna Yakymchuk.

Державне некомерційне підприємство «Національна дитяча спеціалізована лікарня «Охматдит» МОЗ України»

POSTED

DEADLINE

ITB- Supply and delivery of AHS veterinary vaccines [email hidden]

Solicitation # 2026/FNSDN/FNSDN/138908

The Food and Agriculture Organization of the United Nations is seeking offers for the procurement and delivery of AHS veterinary vaccines to Chad. This solicitation, identified as 2026/FNSDN/FNSDN/138908, is managed by the FAO procurement team in Sudan. Interested bidders must possess at least a UNGM Basic Registration with FAO to participate. All offers must be submitted exclusively through the UNGM portal to be considered valid, as any submissions made through other channels will be invalidated.

POSTED

DEADLINE

MEDICAL PHARMACY EMERGENCY NON NSN ORDER

Solicitation # SPE2DP-26-R-0004

Solicitation SPE2DP-26-R-0004 is a Request for Proposal issued on November 4, 2026, by the Department of Defense Medical Supply Chain Pharmacy FSA for the procurement of egg-free Influenza Virus Vaccine, 2027-2028 Formula for adults aged 18 and older. The government intends to award a Firm Fixed Price, Indefinite Delivery, Indefinite Quantity contract to the responsible offeror determined to be most advantageous based on price and non-price factors. Proposals must be submitted electronically via the DIBBS system by December 3, 2026. Award criteria include the proposed unit and total price, agreement to all solicitation terms without exception, and, for large businesses, the submission of a Small Business Subcontracting Plan. The contract mandates strict quality and cold chain management standards, requiring vaccines to be maintained between 2 to 8 degrees Celsius during transportation for up to 72 hours with no acceptable excursions. Products must be delivered to DLA Distribution Susquehanna in New Cumberland, Pennsylvania, and must have an expiration date no later than 18 months after the date of issue from the manufacturer's cold storage. Manufacturers must be FDA current Good Manufacturing Practice acceptable. Packaging and marking must adhere to Medical Marking Standard No. 1D and MIL-STD-129 for perishables. Invoicing and payment will be processed electronically through the Wide Area Workflow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

MEDICAL PHARMACY EMERGENCY NON NSN ORDER

Solicitation # SPE2DP-26-R-0003

Solicitation SPE2DP26R0003 is a request for Injectable Influenza Vaccine 2027 issued by the Department of Defense through DLA Troop Support, based in Philadelphia, Pennsylvania. This procurement falls under NAICS code 325414. The solicitation was posted on November 4, 2026, with a response deadline of December 3, 2026, at 8:00 PM. Primary contact for this effort is Rosbert Jones, with Melissa Rios Thomas serving as the secondary point of contact. Proposals must be submitted electronically via the DIBBS system in accordance with FAR 15.208(a). Submissions are subject to strict technical requirements, including a maximum file size of 10 MB per document and a 60-character limit for file names. File names must not contain spaces and may only use hyphens or underscores as special characters. Acceptable file formats include standard document, image, and spreadsheet extensions such as .pdf, .docx, and .xlsx.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Вакцина для профілактики грипу суспензія для ін'єкцій по 0.5 мл

Solicitation # UA-2026-11-04-002309-a

The Government of Ukraine, specifically the Dnipro Center for Primary Health Care No. 9, is soliciting bids for the procurement of influenza prevention vaccines in 0.5 ml injection suspensions. This solicitation, identified by number UA-2026-11-04-002309-a, was posted on November 4, 2026, with a response deadline set for November 20, 2026. The performance of the contract will take place in Dnipro, Dnipropetrovsk region. A critical requirement for participants is the confirmation that the proposed goods do not originate from the Russian Federation, the Republic of Belarus, or the Islamic Republic of Iran. Interested parties may coordinate with the primary point of contact, Olena Vitaliivna Chayka, regarding the submission of price proposals for this medical procurement.

Комунальне некомерційне підприємство "Дніпровський центр первинної медико-санітарної допомоги № 9" Дніпровської міської ради

POSTED

DEADLINE

iPSC Culture and Differentiation

Solicitation # 75N98027Q00053

The National Institutes of Health, specifically the National Institute of Environmental Health Sciences, intends to award a firm-fixed-price purchase order to Creative Biolabs Inc. for iPSC culture and differentiation services. The scope of work involves culturing, differentiating, and expanding cell populations to over 20 million cells, followed by collection and verification. This effort supports a long-term study to sequence and analyze the complex 4q35 locus on Chromosome 4 using Nanopore Sequencing technology. The government is pursuing a sole-source acquisition because Creative Biolabs is identified as the only provider capable of following the specific required protocols and managing the necessary volume of cell lines within a three-month differentiation window. While the intent is to award to a single source, interested parties may submit capability statements to the designated point of contact by November 13, 2026, to demonstrate their ability to meet the technical and operational requirements.

National Institutes Of Health Olao

POSTED

DEADLINE

Scalable Biologic Manufacturing and FormulationThis subcontract focuses on the development of CMC strategies and scalable production processes for biologic therapies supporting prime contractors on NIH/NINDS projects. The scope of work involves utilizing bioreactors and cleanroom facilities to establish manufacturing processes and formulation strategies, ensuring that all quality attributes are validated in accordance with GMP and regulatory standards for clinical application. The successful provider will be responsible for delivering comprehensive scalable manufacturing documentation, formulated drug products, and detailed quality specifications. This effort is managed under the National Institutes of Health within the Department of Health and Human Services, falling under NAICS code 325414 for biologic product manufacturing.

National Institutes Of Health

POSTED

DEADLINE

Вакцина проти хвороби Ньюкасла із штаму Ла-Сота (100 доз). ДК 021:2015 33650000-1 - Загальні протиінфекційні засоби для системного застосування, вакцини, антинеопластичні засоби та імуномодулятори.

Solicitation # UA-2026-10-29-002284-a

The State Service of Ukraine on Food Safety and Consumer Protection is soliciting bids for the procurement of Newcastle disease vaccine using the La Sota strain. This veterinary medicine contract involves the acquisition of 6,369,000 doses, categorized under general anti-infective agents for systemic use, vaccines, antineoplastic agents, and immunomodulators. The solicitation, identified by number UA-2026-10-29-002284-a, was posted on October 29, 2026, with a response deadline set for November 16, 2026. Performance of the contract will take place within Ukraine as specified in the documentation. Interested parties may contact Alona Tuzynska for further information regarding this government procurement process.

ДЕРЖАВНА СЛУЖБА УКРАЇНИ З ПИТАНЬ БЕЗПЕЧНОСТІ ХАРЧОВИХ ПРОДУКТІВ ТА ЗАХИСТУ СПОЖИВАЧІВ

POSTED

DEADLINE

Вакцина проти класичної чуми свиней (50 доз). ДК 021:2015 33650000-1 - Загальні протиінфекційні засоби для системного застосування, вакцини, антинеопластичні засоби та імуномодулятори.

Solicitation # UA-2026-10-29-001968-a

The Government of Ukraine, through the State Service of Ukraine on Food Safety and Consumer Protection, has issued solicitation UA-2026-10-29-001968-a for the procurement of classical swine fever vaccines. The contract specifies a total requirement of 1,031,000 doses, provided in 50-dose units, for use within veterinary medicine. The solicitation was posted on October 29, 2026, with a response deadline set for November 16, 2026. Performance of the contract will take place within Ukraine as detailed in the official documentation. Interested parties may contact Alona Tuzynska for further inquiries regarding this procurement process.

ДЕРЖАВНА СЛУЖБА УКРАЇНИ З ПИТАНЬ БЕЗПЕЧНОСТІ ХАРЧОВИХ ПРОДУКТІВ ТА ЗАХИСТУ СПОЖИВАЧІВ

POSTED

DEADLINE

Вакцина антирабічна для імунізації тварин (для парентерального застосування). ДК 021:2015 33650000-1 - Загальні протиінфекційні засоби для системного застосування, вакцини, антинеопластичні засоби та імуномодулятори.

Solicitation # UA-2026-10-29-001612-a

The Government of Ukraine, through the State Service of Ukraine on Food Safety and Consumer Protection, has issued solicitation UA-2026-10-29-001612-a for the procurement of anti-rabies vaccines for animal immunization. This contract specifically requires 106,540 doses of vaccines intended for parenteral administration, categorized under general anti-infective agents for systemic use. The solicitation was posted on October 29, 2026, with a response deadline set for November 16, 2026. Performance of the contract will take place within Ukraine as specified in the documentation. Interested parties can coordinate through the primary point of contact, Alona Tuzynska, via the provided agency email or phone number.

ДЕРЖАВНА СЛУЖБА УКРАЇНИ З ПИТАНЬ БЕЗПЕЧНОСТІ ХАРЧОВИХ ПРОДУКТІВ ТА ЗАХИСТУ СПОЖИВАЧІВ

POSTED

DEADLINE

Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)

Solicitation # 12639527R0001

Solicitation 12639527R0001 is a request for proposal issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an unrestricted, IDIQ contract focused on Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC). The scope of work includes the purchase and storage of VAC, the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract features a ceiling price of 800 million dollars and a long-term performance horizon, consisting of five one-year ordering periods for VAC and direct purchases starting December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The contractor is required to produce VAC with a minimum capacity of 1.0 million doses and maintain storage on their premises under strict quality control and temperature monitoring standards. Due to the nature of the material, live FMDV is classified as a Tier 1 Select Agent, requiring specific authorization from the CDC/APHIS and adherence to rigorous shipping and security restrictions. Award will be based on the most advantageous offer, evaluating technical capability, past performance, and price, with technical and past performance factors weighted equally. Proposals must be submitted electronically in four separate volumes by November 10, 2026.

Mrpbs Minneapolis Mn

POSTED

14 days ago

DEADLINE

in about 9 hours

AI Contract Overview

The Government of Canada, through the Department of Public Works and Government Services, is seeking to establish a Secondary Pandemic Influenza Vaccine Readiness and Supply Contract. The objective is to secure access to up to 25 million doses of a pandemic influenza vaccine suitable for adults and children six months of age and older. Selected contractors must maintain a state of pandemic readiness and provide a vaccine that meets safety and immunogenicity standards against pandemic strains identified by the World Health Organization. This solicitation, numbered WS4698221354, requires interested parties to access the full Request for Proposal and associated documents via a registered SAP Ariba account. The response deadline for this federal procurement opportunity is June 11, 2025. All performance will take place within Canada, and inquiries are directed to the primary point of contact, Lina Chan.

General Info

Canada seeks contractors for up to 25 million pandemic influenza vaccine doses by 2025.

Agency

Government of Canada → Department of Public Works and Government Services

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

*Canada, CAN

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

1 update

PhaseClosed

PostedAug 23

Solicitation

Response DeadlineJun 11

Deadline has passed

Notice updatedMar 12

Response deadline changed from Sep 5, 2024 to Jun 11, 2025. The notice title changed. The notice description changed.

Submission Closed

06/11/2025, 02:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyGovernment of Canada → Department of Public Works and Government Services

Contacts1 person available

OfficeN/A

Organization / AgencyGovernment of Canada → Department of Public Works and Government Services

Office AddressN/A

Contacts

Chan Lina (SPAC/PSPC) (elle-la / she-herPoint of Contact

contact@example.gov

Full Description

Canada has a requirement to establish a new Secondary Pandemic Influenza Vaccine (PIV) Readiness and Supply Contract(s) to access up to 25 million doses of PIV. The Contractor(s) must have and maintain a state of pandemic readiness and be able to supply an in?uenza vaccine (inclusive of adjuvant, if applicable) that is indicated for the active immunization of adults and children six (6) months of age and older and which demonstrates an acceptable level of safety and immunogenicity against the relevant pandemic in?uenza virus strain(s) identified by the World Health Organization (WHO). The full Request for Proposal (RFP) and attachments can only be accessed and downloaded when logged into your SAP Ariba account and have filled out your Government of Canada profile. The web link to login to SAP Ariba (or to register for an SAP Ariba account) can be found under the Bidding details tab. Additional details can be found on the Ariba Discovery Posting and the Notice of Proposed Procurement (NPP) here: https://discovery.ariba.com/rfx/23130346 .